Third, our strategy could reprogram the postsurgery immunosuppressive TME by promoting DCs maturation, increasing the percentage of NK cells, enhancing the infiltration of effector T cells, and decreasing the number of MDSC in mice's main immune organs, leading to maximized antitumour immunity of anti‐PD‐L1 for synergistic cancer immunotherapy. This evidence concerns the gene CD274 and cancer.